Changing profile of encephalitis: Results of a 4-year study in France.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 19 06 2021
revised: 01 11 2021
accepted: 26 11 2021
pubmed: 14 12 2021
medline: 2 2 2022
entrez: 13 12 2021
Statut: ppublish

Résumé

In 2007, we performed a nationwide prospective study to assess the epidemiology of encephalitis in France. We aimed to evaluate epidemiological changes 10years later. We performed a 4-year prospective cohort study in France (ENCEIF) from 2016 to 2019. Medical history, comorbidities, as well as clinical, biological, imaging, and demographic data were collected. For the comparison analysis, we selected similar data from adult patients enrolled in the 2007 study. We used Stata statistical software, version 15 (Stata Corp). Indicative variable distributions were compared using Pearson's Chi We analyzed 494 cases from 62 hospitals. A causative agent was identified in 65.7% of cases. Viruses represented 81.8% of causative agents, Herpesviridae being the most frequent (63.6%). Arboviruses accounted for 10.8%. Bacteria and parasites were responsible for respectively 14.8% and 1.2% of documented cases. Zoonotic infections represented 21% of cases. When comparing ENCEIF with the 2007 cohort (222 adults patients from 59 hospitals), a higher proportion of etiologies were obtained in 2016-2019 (66% vs. 53%). Between 2007 and 2016-2019, the proportions of Herpes simplex virus and Listeria encephalitis cases remained similar, but the proportion of tuberculosis cases decreased (P=0.0001), while tick-borne encephalitis virus (P=0.01) and VZV cases (P=0.03) increased. In the 2016-2019 study, 32 causative agents were identified, whereas only 17 were identified in the 2007 study. Our results emphasize the need to regularly perform such studies to monitor the evolution of infectious encephalitis and to adapt guidelines.

Identifiants

pubmed: 34896660
pii: S2666-9919(21)00545-5
doi: 10.1016/j.idnow.2021.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

A Mailles (A)

Santé Publique France, Saint-Maurice, France; ESCMID Study Group on the infections of the Brain (ESGIB), Basel, Switzerland. Electronic address: Alexandra.mailles@santepubliquefrance.fr.

X Argemi (X)

Infectious diseases and internal medicine department, Axium clinic, Aix-en-Provence, France.

C Biron (C)

Infectious diseases department, CHU Hôtel-Dieu, INSERM UIC 1413, Nantes university, Nantes, France.

P Fillatre (P)

ESCMID Study Group on the infections of the Brain (ESGIB), Basel, Switzerland; Intensive care unit, hôpital Yves-le-Foll, Saint-Brieuc, France.

T De Broucker (T)

Neurology, CH Delafontaine, Saint-Denis, France.

R Buzelé (R)

Infectious diseases unit, hôpital Yves-le-Foll, Saint-Brieuc, France.

A Gagneux-Brunon (A)

Infectious diseases department, hôpital Nord, CHU Saint-Étienne, Saint-Priest-en-Jarez, France.

I Gueit (I)

Department of infectious diseases, CHU Rouen, Rouen, France.

C Henry (C)

Neurology, CH Delafontaine, Saint-Denis, France.

S Patrat-Delon (S)

Infectious diseases department, CHU Ponchaillou, Rennes, France.

A Makinson (A)

Infectious diseases and intensive care unit, Pontchaillou university hospital, Rennes, France.

E Piet (E)

Infectious diseases department, CH Annecy-Genevois, Metz Tessy, France.

H Wille (H)

Infectious diseases department, CH Côte Basque, 64109 Bayonne, France.

M O Vareil (MO)

Infectious diseases department, CH Côte Basque, 64109 Bayonne, France.

O Epaulard (O)

ESCMID Study Group on the infections of the Brain (ESGIB), Basel, Switzerland; Université Grenoble Alpes, CHUGA, infectious diseases department, Grenoble, France.

M Martinot (M)

Infectious diseases department CH Colmar, Colmar, France.

P Tattevin (P)

ESCMID Study Group on the infections of the Brain (ESGIB), Basel, Switzerland; Infectious diseases department, CHU Ponchaillou, Rennes, France.

J P Stahl (JP)

ESCMID Study Group on the infections of the Brain (ESGIB), Basel, Switzerland; Université Grenoble Alpes, CHUGA, infectious diseases department, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH